Pembrolizumab in Locally Advanced Sinonasal Carcinoma
Pembrolizumab in Locally Advanced Sinonasal Carcinoma
Recruiting · NCT05925491 · Registry updated 2026-04-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab in Locally Advanced Sinonasal Carcinoma | sinonasal undifferentiated carcinoma | Recruiting | Phase 2 | 2026-04-16 | NCT05925491 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Istituti Clinici Scientifici Maugeri SpA | 75 |
| Merck Sharp & Dohme LLC | 650 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Istituti Clinici Scientifici Maugeri | Pavia | Italy | 2 |